Home Actualité internationale World news – Celsion receives the Fast Track designation for cancer immunotherapy
Actualité internationale

World news – Celsion receives the Fast Track designation for cancer immunotherapy

The FDA has recognized Celsions GEN-1, a phase 2 immunotherapy for advanced ovarian cancer, as a Fast Track.

[quads id=1]